36447045|t|Tau and GSK-3beta are Critical Contributors to alpha-Synuclein-Mediated Post-Stroke Brain Damage.
36447045|a|Post-stroke secondary brain damage is significantly influenced by the induction and accumulation of alpha-Synuclein (alpha-Syn). alpha-Syn-positive inclusions are often present in tauopathies and elevated tau levels and phosphorylation promotes neurodegeneration. Glycogen synthase kinase 3beta (GSK-3beta) is a known promoter of tau phosphorylation. We currently evaluated the interaction of alpha-Syn with GSK-3beta and tau in post-ischemic mouse brain. Transient focal ischemia led to increased cerebral protein-protein interaction of alpha-Syn with both GSK-3beta and tau and elevated tau phosphorylation. Treatment with a GSK-3beta inhibitor prevented post-ischemic tau phosphorylation. Furthermore, alpha-Syn interaction was observed to be crucial for post-ischemic GSK-3beta-dependent tau hyperphosphorylation as it was not seen in alpha-Syn knockout mice. Moreover, tau knockout mice show significantly smaller brain damage after transient focal ischemia. Overall, the present study indicates that GSK-3beta catalyzes the alpha-Syn-dependent tau phosphorylation and preventing this interaction is crucial to limit post-ischemic secondary brain damage.
36447045	8	17	GSK-3beta	Gene	56637
36447045	47	62	alpha-Synuclein	Gene	20617
36447045	72	96	Post-Stroke Brain Damage	Disease	MESH:D001925
36447045	98	109	Post-stroke	Disease	MESH:D020521
36447045	120	132	brain damage	Disease	MESH:D001925
36447045	198	213	alpha-Synuclein	Gene	20617
36447045	215	224	alpha-Syn	Gene	20617
36447045	227	236	alpha-Syn	Gene	20617
36447045	278	289	tauopathies	Disease	MESH:D024801
36447045	343	360	neurodegeneration	Disease	MESH:D019636
36447045	362	392	Glycogen synthase kinase 3beta	Gene	56637
36447045	394	403	GSK-3beta	Gene	56637
36447045	491	500	alpha-Syn	Gene	20617
36447045	506	515	GSK-3beta	Gene	56637
36447045	527	531	post	Disease	MESH:D000094025
36447045	532	540	ischemic	Disease	MESH:D002545
36447045	541	546	mouse	Species	10090
36447045	570	578	ischemia	Disease	MESH:D007511
36447045	636	645	alpha-Syn	Gene	20617
36447045	656	665	GSK-3beta	Gene	56637
36447045	725	734	GSK-3beta	Gene	56637
36447045	755	759	post	Disease	MESH:D000094025
36447045	760	768	ischemic	Disease	MESH:D002545
36447045	803	812	alpha-Syn	Gene	20617
36447045	856	860	post	Disease	MESH:D000094025
36447045	861	869	ischemic	Disease	MESH:D002545
36447045	870	879	GSK-3beta	Gene	56637
36447045	937	946	alpha-Syn	Gene	20617
36447045	956	960	mice	Species	10090
36447045	985	989	mice	Species	10090
36447045	1017	1029	brain damage	Disease	MESH:D001925
36447045	1052	1060	ischemia	Disease	MESH:D007511
36447045	1104	1113	GSK-3beta	Gene	56637
36447045	1128	1137	alpha-Syn	Gene	20617
36447045	1220	1224	post	Disease	MESH:D000094025
36447045	1225	1233	ischemic	Disease	MESH:D002545
36447045	1244	1256	brain damage	Disease	MESH:D001925
36447045	Association	MESH:D020521	20617
36447045	Association	MESH:D024801	20617
36447045	Association	MESH:D001925	20617
36447045	Association	MESH:D019636	20617
36447045	Association	20617	56637
36447045	Association	MESH:D002545	56637
36447045	Association	MESH:D000094025	56637
36447045	Positive_Correlation	MESH:D007511	20617
36447045	Association	MESH:D007511	56637
36447045	Association	MESH:D001925	56637

